Literature DB >> 6431476

Methysergide decreases prolactin release after FK 33-824 [Tyr-D-Ala-Gly-MePhe-Met(o)-ol], a potent analogue of methionine enkephalin. A study in man.

G Jungkunz, N Nedopil, E Rüther.   

Abstract

This study investigated the mechanisms which may underly the prolactin (PRL) stimulating effects of FK 33-824, a potent enkephalin analogue. FK 33-824 (1 mg) was infused in healthy volunteers before and after pretreatment with 3 mg methysergide, a serotonin receptor blocker. All subjects showed a release of PRL after FK 33-824, which was significantly diminished after pretreatment with methysergide.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6431476     DOI： 10.1007/bf00429737

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


  19 in total

1.  Stimulation of prolactin secretion by morphine: role of the central serotonergic system.

Authors:  J I Koenig; M A Mayfield; S M McCann; L Krulich
Journal:  Life Sci       Date:  1979-09-03       Impact factor: 5.037

2.  Relation of endogenous opioid peptides and morphine to neuroendocrine functions.

Authors:  J Meites; J F Bruni; D A Van Vugt; A F Smith
Journal:  Life Sci       Date:  1979-04-09       Impact factor: 5.037

3.  Involvement of brain serotonin in the prolactin-releasing effect of opioid peptides.

Authors:  S Spampinato; V Locatelli; D Cocchi; L Vicentini; S Bajusz; S Ferri; E E Müller
Journal:  Endocrinology       Date:  1979-07       Impact factor: 4.736

4.  p-Chlorophenylalanine: a specific depletor of brain serotonin.

Authors:  B K Koe; A Weissman
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

5.  Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat.

Authors:  D Cocchi; V Locatelli; R Carminati; E E Müller
Journal:  Life Sci       Date:  1978-09-04       Impact factor: 5.037

6.  Morphine and endorphins modulate dopamine turnover in rat median eminence.

Authors:  S N Deyo; R M Swift; R J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

7.  Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.

Authors:  B Allolio; W Winkelmann; F X Hipp; D Kaulen; R Mies
Journal:  J Clin Endocrinol Metab       Date:  1982-07       Impact factor: 5.958

8.  Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin.

Authors:  C Rivier; W Vale; N Ling; M Brown; R Guillemin
Journal:  Endocrinology       Date:  1977-01       Impact factor: 4.736

9.  Beta-endorphin-induced decrease in hypothalamic dopamine turnover.

Authors:  G R van Loon; D Ho; C Kim
Journal:  Endocrinology       Date:  1980-01       Impact factor: 4.736

10.  Cholinergic and histaminergic involvement in the growth hormone releasing effect of an enkephalin analog FK 33-824 in man.

Authors:  A Peñalva; L Villanueva; F Casanueva; F Cavagnini; A Gomez-Pan; E E Müller
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530
View more
  1 in total

1.  Effects of methysergide, bromocriptine and naloxone on prolactin, growth hormone and TSH release induced by D-Met2,Pro5-enkephalinamide in man.

Authors:  J Földes; A Váradi; A Gara; C Bános; P Vargha; K Török; J I Székely
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.